Transcription is an important first step in the conversion of genetic information in the DNA into proteins, and is the main link in the control of gene expression. Transcription of protein-coding genes is accomplished by the multi-subunit enzyme RNA polymerase II and an ensemble of ancillary proteins which is called transcription factors (TFs). TFs play an important role in the long-term regulation of cell growth, differentiation and response to environmental signals. Recently, interest has focused on the study of small molecules targeting TFs, which contribute to the investigation of the pathogenesis of a wide range of human diseases, such as diabetes, inflammatory diseases and cardiovascular diseases. Therefore, these proteins have great therapeutic potential.
BOC Sciences has designed a dedicated set of more than 9,200 transcription-related screening compounds with validated transcription factor targets modulating properties for high-throughput screening. Our library of transcription factor targeted compounds is a useful tool for studying transcription factors as drug targets, and regulating TFs for different therapeutic applications.
Figure 1. Mechanisms of HIF Stabilization by Immune Cells (A) O2 dependent. (Palazon, A.; et al. 2014)
The search is performed against the following transcription-related protein targets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BOC Sciences provides professional, rapid and high-quality services of Transcription-related Screening Library design at competitive prices for global customers. Personalized and customized services of Transcription-related Screening Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.